Alnylam Pharmaceuticals
ABOUT ALNYLAM
Our Science Is Changing the Way Medicine Treats DiseaseTM
Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines. Founded in 2002 by a team of distinguished life sciences leaders, Alnylam’s vision is to harness the potential of RNAi therapeutics to transform the lives of people living with diseases for which there are limited or inadequate treatment options. Our pioneering work has delivered the world’s first and only approved RNAi therapeutics—ONPATTRO® (patisiran) in 2018, GIVLAARI® (givosiran) in 2019, OXLUMO® (lumasiran) in 2020, and AMVUTTRA® (vutrisiran) in 2022. We are advancing a deep pipeline of innovative RNAi-based medicines in four therapeutic areas: genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases.
What’s in a Name?
AL-NY-LAM. Our name may not be the easiest to pronounce, but once you learn it, you’ll never forget it. Alnylam is derived from “Alnilam,” the bright center star in the constellation Orion’s belt, which has been used by navigators for thousands of years and symbolizes our passion for discovery.
RNAi Therapeutics—An Innovative New Class of Medicines
Medicines based on RNAi work by “silencing” or disabling the production (“expression”) of the genes that cause specific diseases. In doing so, RNAi therapeutics work “upstream” of most other classes of medicines, such as small molecules and monoclonal antibodies, by targeting the “root” genetic cause of a disease rather than its symptoms. To learn more about our science, click here.
RNAi is the core discovery that forms the therapies Alnylam is developing. It is recognized as a major scientific breakthrough—but how does it work, exactly?
Vision, Mission, and Values
Our Vision - Harnessing a revolution in biology for human health®.
Our Mission - Build a top-tier, global, independent biopharmaceutical company founded on RNAi.
Our Core Values - Commitment to People, Innovation & Discovery, Sense of Urgency, Open Culture, and Passion for Excellence.
CAREERS AT ALNYLAM
Join Our Team and Grow With Us
At Alnylam, we are driven by our mission to translate the Nobel Prize-winning discovery of RNA interference (RNAi) into an innovative, new class of medicines. We’re motivated in this endeavor by the bravery and perseverance of people with unmet medical needs who live with rare and genetic diseases. They are the focus of our efforts, and we exist as a company because of them. That knowledge and commitment to patients is present in everything we do, every day.
At The Forefront of What’s Next
For Patients
Our goal, which is well underway, is to become a world-class biopharmaceutical company that can independently develop and deliver innovative medicines based on RNAi to patients worldwide. We have a deep pipeline of early to late stage investigational therapies, and 2018 marked the approval of our first medicine—the world’s first RNAi therapeutic. Even though we’ve been around since 2002, we’re just getting started!
For Employees
We are growing quickly and hiring across North America, Europe, Asia, and Latin America for a wide variety of roles. We’re seeking smart, passionate, “change the world” kind of people who are ready to say, “challenge accepted.” Our 1,500 (and counting!) employees are building a diverse, equitable, inclusive, and high-performing global organization that celebrates team achievement and recognizes individual contributions.
We’re at the forefront of what’s next for patients, and perhaps your career also.
Search among Alnylam Pharmaceuticals jobs
| Jobs: 1 - 10 of 101 |
Strategic Account Lead, Site of Care
Cambridge, Massachusetts
Overview Reporting to the Site of Care National Director, the Strategic Account Lead, Site of Care will optimize access to Alnylam products through strategic engagement and contracting with Alternate Site of Care accounts. This position req...
9h
| Job Type | Full Time |
Cambridge, Massachusetts
Overview The Clinical Risk Analyst - Site Profile (CRA-SP), Clinical Risk & Analytics (CR&A) reports into the CR&A function and is responsible for the delivery of timely and high-quality Site Profile assessments and analytics for clinical t...
9h
| Job Type | Full Time |
Sr. Manager, Quality Assurance
Cambridge, Massachusetts
Overview The Senior Manager, Clinical Systems Quality Lead, is responsible for developing and implementing the process and framework for the assessment and management of GCP technologies across Alnylam Clinical programs, including developme...
23h
| Job Type | Full Time |
Cambridge, Massachusetts
Overview Alnylam Pharmaceuticals is seeking a Director, Study Start-up to join our dynamic and growing team. The Director, Study Start-Up (SSU) provides strategic, operational and people leadership across the study start-up portfolio, with ...
23h
| Job Type | Full Time |
Associate Director, Study Start Up
Cambridge, Massachusetts
Overview Alnylam Pharmaceuticals is seeking a Associate Director, Study Start-up to join our dynamic and growing team. The Associate Director, Study Start-Up (SSU) provides tactical and operational leadership for assigned studies or program...
23h
| Job Type | Full Time |
Cambridge, Massachusetts
Manager, Medical Research The Manager, Medical Research is responsible for managing and coordinating operational activities for medical affairs studies including global observational studies, local/regional studies, disease registries and e...
23h
| Job Type | Full Time |
Cambridge, Massachusetts
Responsibilities: The Director,Epidemiologyis responsible for representing the Epidemiology function at Alnylam providing expertise, strategic vision, and oversight of epidemiology and real-world evidence (RWE) activities in support of all ...
23h
| Job Type | Full Time |
VP, Medical Affairs Head of Early Assets
Cambridge, Massachusetts
Overview The Vice President, Head of Early Assets, serves as the strategic and scientific leader for Alnylam's earlystage medical programs across CNS, cardiovascular, and hematology indications. As a key member of the Medical Affairs Leader...
23h
| Job Type | Full Time |
Director, Clinical Research-Cardiology
Cambridge, Massachusetts
Overview Alnylam Pharmaceuticals is seeking an imaginative physician drug developer, with the flexibility and confidence to work in therapeutic areas that may be beyond their particular expertise or experience. This is an opportunity to pro...
23h
| Job Type | Full Time |
Executive Director, Head of Medical Excellence, Operations, and Planning
Cambridge, Massachusetts
Overview Reporting to the SVP, Head of Medical Affairs, the Executive Director, Head of Medical Excellence, Operations, and Planning is a senior operational and strategic leader within Global Medical Affairs and a key member of the Medical ...
23h
| Job Type | Full Time |